NSF believe that the key to business success is to become less risk averse and more risk smart. In this short and concise document, NSF discuss key issues relating to risk management for pharmaceutical companies such as the fear of taking risks, complacency in the work place, ageing facilities and more.
Get risk ready for 2018
NSF's new pharma journal focuses on risk management, with a detailed article on becoming risk smart and a closer look into ICH Q9, quality risk management
You may also like
Regulatory
![Why SLTs fail on the PQS/QMS: The leadership gap undermining quality]()
Why SLTs fail on the PQS/QMS: The leadership gap undermining quality
Read moreSenior leadership teams hold the ultimate responsibility for an effective Pharmaceutical Quality System. Yet across the industry, PQS failures remain one of the most consistent findings in regulatory inspections. Why?
Trending Articles
You may also like
Regulatory
![NSF Pharma Biotech Conference Q&A highlights priorities for contamination control, quality culture and workforce development]()
NSF Pharma Biotech Conference Q&A highlights priorities for contamination control, quality culture and workforce development
The discussion underscored the growing importance of aligning employee behaviours with compliance objectives, while also addressing the industry’s ongoing challenges around regulatory benchmarking and operational consistency
